Hepatocellular carcinoma (HCC) remains challenging to treat in advanced stages, primarily due to the development of resistance to sorafenib. There is ...

and KEYNOTE-365 which is investigating multiple combinations with other drugs given on top of first-line hormonal therapy. Hepatocellular carcinoma (HCC) – the most common form of liver cancer ...

Hepatic artery infusion (HAI) therapy offers a new approach for people whose colorectal cancer has spread to the liver. It ...

Combining EPO inhibition with an immunotherapy that further activates these immune cells against the cancer led to complete regression of existing liver tumors in the majority of treated mice ...

Blocking the activity of the protein turns formerly "cold," or immune-resistant, liver tumors in mice into "hot" tumors teeming with cancer-fighting immune cells. When combined with an ...